SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037842
Filing Date
2020-08-06
Accepted
2020-08-06 16:45:43
Documents
59
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q onct-10q_20200630.htm   iXBRL 10-Q 1845436
2 EX-10.4 onct-ex104_122.htm EX-10.4 11567
3 EX-31.1 onct-ex311_8.htm EX-31.1 16967
4 EX-31.2 onct-ex312_15.htm EX-31.2 16953
5 EX-32.1 onct-ex321_7.htm EX-32.1 6744
6 EX-32.2 onct-ex322_13.htm EX-32.2 6934
  Complete submission text file 0001564590-20-037842.txt   5765058

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA onct-20200630.xsd EX-101.SCH 52534
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onct-20200630_cal.xml EX-101.CAL 31215
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onct-20200630_def.xml EX-101.DEF 168987
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20200630_lab.xml EX-101.LAB 366132
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20200630_pre.xml EX-101.PRE 275640
12 EXTRACTED XBRL INSTANCE DOCUMENT onct-10q_20200630_htm.xml XML 756862
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 201082389
SIC: 2834 Pharmaceutical Preparations